π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
This study is a prospective, single-center, open-label, umbrella-shaped pha...
Status
Unknown
Location
Cancer Hospital Affiliated to Fudan University
Start Date
2020-05-01
Trial ID
NCT04355858
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This study is being conducted to explore the efficacy and safety of SHR-102...
Status
Unknown
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2021-04-22
Trial ID
NCT04814485
Treatments Being Tested
This review will evaluate the efficacy and safety of SHR1210 (Camrelizumab)...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2023-06-01
Trial ID
NCT05862064
Treatments Being Tested
The purpose of this study is to establish a prospective, multi-center platf...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2022-12-30
Trial ID
NCT05594095
This study is an open-label, multi-center Phase II clinical study, aimed to...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-06-30
Trial ID
NCT07627620
Treatments Being Tested
This is a randomized, open-label, 3-arm Phase 2 study to evaluate the effic...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2021-04-05
Trial ID
NCT04680988
Treatments Being Tested
The study is being conducted to evaluate the Opportune Administration of Na...
Status
Unknown
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2023-03-01
Trial ID
NCT05670925
Treatments Being Tested
This is an open, randomized, controlled, multicenter Phase III clinical stu...
Status
Recruiting
Location
Breast cancer institute of Fudan University Cancer Hospital
Start Date
2023-08-20
Trial ID
NCT05999149
Treatments Being Tested
This prospective, single-arm trial explores the efficacy of Adibelimab mono...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-03-30
Trial ID
NCT06336954
Treatments Being Tested